Feed aggregator

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming February 21, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN) securities between February 23, 2022 and December 17, 2024, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ASTRAZENECA PLC (AZN), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE

DALLAS--(BUSINESS WIRE)--Generational Group, a leading mergers and acquisitions advisory firm for privately held businesses, is pleased to announce the sale of its client, Moving Forward, LLC, to WellRive. The acquisition closed May 1, 2024. Located in Madison, Wisconsin, Moving Forward, LLC, affiliated with the National Association of Senior & Specialty Move Managers®, is renowned for assisting seniors and their families with the complexities of downsizing and relocating in the Madison are

CHICAGO--(BUSINESS WIRE)-- #banking--Credit Union Wealth Group launches its credit union investment management services, offering a suite of managed bond products for credit unions.

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Nextracker Inc. (“Nextracker” or the “Company”) (NASDAQ: NXT) common stock between February 1, 2024 and August 1, 2024, inclusive (the “Class Period”). Nextracker investors have until February 25, 2025 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN NEXTRACKER INC. (NXT), CONTACT THE LAW OFFICES OF HOWARD G. SMITH

LOS ANGELES--(BUSINESS WIRE)--Thumzup Media Corporation ("Thumzup" or the "Company") (Nasdaq: TZUP), an emerging leader in social media branding and programmatic marketing solutions, today announced that it has purchased 9.783 Bitcoin (“BTC”) for approximately $1 million, at an average price of $102,220 per BTC. Management is requesting authorization from its Board of Directors to hold up to 90% of its liquid assets in BTC for additional, ongoing Bitcoin purchases as part of its Treasury Asset

NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns preliminary ratings to six classes of mortgage pass-through notes from Verus Securitization Trust 2025-1 (VERUS 2025-1), a $553.2 million non-prime RMBS transaction. The underlying collateral, comprised of 1,178 residential mortgages, is characterized by a significant concentration of loans underwritten using alternative income documentation. Borrowers in the subject pool possess a non-zero WA original credit score of 743 and exhibit moderate equity in ea

RUSTON, La.--(BUSINESS WIRE)--Representatives from the Federal Home Loan Bank of Dallas (FHLB Dallas), Origin Bank and Century Next Bank will award a $60,000 grant to Zion Traveler Community Development Inc. Under the Partnership Grant Program, FHLB Dallas member institutions contribute $500 to $5,000 to a nonprofit, which FHLB Dallas matches at a 5:1 ratio to provide up to $25,000 to the organization per member. The awards help promote and strengthen relationships between community-based nonpr

IRVINE, Calif.--(BUSINESS WIRE)-- #HPI--CoreLogic®, a leading global property information, analytics and data-enabled solutions provider, today released the CoreLogic Home Price Index (HPI™) and HPI Forecast™ for November 2024. U.S. home price gains remained static since the summer of 2022 in November, but 17 states reached new highs, with the nation as a whole expected to see a new peak this April, as the typically busy homebuying season launches into full swing. The growth comes as Freddie Mac annou

SAN FRANCISCO--(BUSINESS WIRE)--Grove AI, a next-generation clinical trial management and intelligence company, today announced a $4.9 million seed fundraise led by A*, with participation from Afore Capital, LifeX Ventures, Pear VC, Upfront Ventures, and industry-leading angels. This investment will allow Grove to continue scaling its team and product to redefine clinical trials from siloed operations into participant-centered ecosystems driven by real-time data. Despite their vital role in adv